FDA Inspection 1143106 — Dakhil, Dr Shaker
The FDA completed an inspection of Dakhil, Dr Shaker on May 21, 2021 in Wichita, KS. The inspection was classified VAI (Voluntary Action Indicated — objectionable conditions were found but do not meet the threshold for regulatory action). Product area: Drugs.
Inspection Details
- Classification
- Voluntary Action Indicated (VAI) (VAI)
- End Date
- May 21, 2021
- Fiscal Year
- 2021
- Product Type
- Drugs
- Project Area
- Bioresearch Monitoring
- Location
- Wichita, KS (United States)
Additional Details
Clinical Investigator (CI)